1. Home
  2. VYGR vs GENC Comparison

VYGR vs GENC Comparison

Compare VYGR & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.74

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Logo Gencor Industries Inc.

GENC

Gencor Industries Inc.

HOLD

Current Price

$14.50

Market Cap

232.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
GENC
Founded
2013
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Construction/Ag Equipment/Trucks
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
232.2M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
VYGR
GENC
Price
$3.74
$14.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$21.00
$16.00
AVG Volume (30 Days)
862.4K
25.3K
Earning Date
03-09-2026
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.08
EPS
N/A
0.23
Revenue
$10,135,000.00
$48,943,000.00
Revenue This Year
$54.19
$6.36
Revenue Next Year
$20.22
$8.32
P/E Ratio
N/A
$61.43
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$10.80
52 Week High
$5.55
$17.40

Technical Indicators

Market Signals
Indicator
VYGR
GENC
Relative Strength Index (RSI) 42.89 45.39
Support Level $3.36 $13.56
Resistance Level $3.74 $14.68
Average True Range (ATR) 0.32 0.54
MACD -0.06 -0.19
Stochastic Oscillator 4.87 28.89

Price Performance

Historical Comparison
VYGR
GENC

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.

Share on Social Networks: